SEC Filing Summary: Marathon Patent Group, Inc. (8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Marathon Patent Group, Inc. on December 9, 2016. The filing discloses the entry into a material definitive agreement regarding a registered direct offering of common stock and a concurrent private placement of warrants.
Key Financial Metrics and Transaction Details
The filing details a capital raise transaction with the following terms:
- Common Stock Sale: 3,481,997 shares sold at $1.50 per share.
- Warrant Sale: 1,740,995 warrants sold at $0.01 per warrant.
- Warrant Terms: Exercisable after six months for a five-year period at an exercise price of $1.70 per share.
- Placement Agent Fees: Northland Securities, Inc. received a fee of $365,610 (7% of gross proceeds) plus an agent's warrant to purchase 174,100 shares at $1.725 per share.
- Closing Date: Expected on or about December 14, 2016.
The filing text does not provide clear values for the company's historical revenue, profit, cash flow, margins, debt, or liquidity positions.
Material Changes
The primary material change is the dilution of existing shareholders due to the issuance of new shares and warrants. The company agreed to register the resale of shares underlying the warrants on a Form S-1 within 30 days of the offering.
Outlook, Risks, and Contingencies
The transaction is subject to customary closing conditions. The company relied on Section 4(a)(2) of the Securities Act of 1933 for the exemption of the warrant sales from registration. No specific forward-looking guidance or management commentary regarding future operations was included in this specific filing.
Key Facts for Investor Verification
- Verify the actual closing date and confirmation of gross proceeds received.
- Confirm the filing and effectiveness of the Form S-1 registration statement for warrant shares within the mandated 30 to 90-day window.
- Assess the immediate dilution impact of the 3,481,997 new shares and 1,740,995 investor warrants.
- Review the full text of the Securities Purchase Agreement and Registration Rights Agreement (Exhibits 10.1 and 10.2) for specific covenants.